Sign In
Buy MDT
Medtronic Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -22.40. In total, the insiders bought 735.84K and sold 216.57K MDT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-22.40 |
| ● Buy | 735.84K shares |
| ● Sell | 216.57K shares |
|
53% Buy Activity
Weak Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 27, 2026 Buy |
Lee Joon Sup Director |
1 803 Value: $149.5K |
||
|
Apr 27, 2026 Buy |
Lewis Gregory P Director |
2 111 Value: $175.0K |
||
|
Apr 27, 2026 Buy |
Lofton Kevin E Director |
2 111 Value: $175.0K |
||
|
Apr 27, 2026 Buy |
Nabel Elizabeth G Director |
2 111 Value: $175.0K |
||
|
Apr 27, 2026 Buy |
Powell Kendall J Director |
2 111 Value: $175.0K |
||
|
Apr 27, 2026 Buy |
Blomquist Denise L. Chief Accounting Officer |
1 508 Value: $125.0K |
||
|
Apr 27, 2026 Buy |
Fonseca Lidia Director |
2 111 Value: $175.0K |
||
|
Apr 27, 2026 Buy |
Donnelly Scott C Director |
2 111 Value: $175.0K |
||
|
Apr 27, 2026 Buy |
Arnold Craig Director |
2 111 Value: $175.0K |
||
|
Mar 03, 2026 Sell |
Pieton Thierry EVP & Chief Financial Officer |
2 976 Value: $287.8K |
||
|
Feb 20, 2026 Sell |
Blomquist Denise L. Chief Accounting Officer |
340 Value: $0 |
||
|
Feb 19, 2026 Buy |
Kiil Harry Skip EVP & President Cardiovascular |
385 Value: $30.8K |
||
|
Feb 19, 2026 Buy |
Kiil Harry Skip EVP & President Cardiovascular |
30 568 Value: $2.85M |
||
|
Feb 19, 2026 Buy |
Kiil Harry Skip EVP & President Cardiovascular |
19 923 Value: $1.75M |
||
|
Feb 19, 2026 Sell |
Kiil Harry Skip EVP & President Cardiovascular |
385 Value: $37.7K |
||
|
Feb 19, 2026 Sell |
Kiil Harry Skip EVP & President Cardiovascular |
668 Value: $65.3K |
||
|
Feb 19, 2026 Sell |
Kiil Harry Skip EVP & President Cardiovascular |
19 255 Value: $1.88M |
||
|
Feb 19, 2026 Sell |
Kiil Harry Skip EVP & President Cardiovascular |
30 568 Value: $2.99M |
||
|
Feb 19, 2026 Buy |
Kiil Harry Skip EVP & President Cardiovascular |
30 568 Value: $2.85M |
||
|
Feb 19, 2026 Sell |
Kiil Harry Skip EVP & President Cardiovascular |
1 648 Value: $161.3K |
||
|
Feb 19, 2026 Buy |
Kiil Harry Skip EVP & President Cardiovascular |
19 923 Value: $1.75M |
||
|
Feb 19, 2026 Buy |
Kiil Harry Skip EVP & President Cardiovascular |
385 Value: $30.8K |
||
|
Jan 29, 2026 Sell |
Blomquist Denise L. Chief Accounting Officer |
148 Value: $14.9K |
||
|
Dec 15, 2025 Sell |
Martha Geoffrey Chairman And CEO |
1 564 Value: $156.2K |
||
|
Dec 15, 2025 Sell |
Marinaro Michael EVP, Pres Medsurg And Americas |
1 371 Value: $136.9K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
